AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Ocrelizumab in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Ocrelizumab Solution For Infusion | ZAMRA-HM-24-82 | Roche Products | active | 28 Dec 2029 |
Ocrelizumab — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Ocrelizumab, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Ocrelizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.